FDA Announces Joint Meeting of Psychopharmacologic Drugs and Drug Safety Committees

Summary

The FDA is hosting a public meeting of the Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, where the committees will provide advice on regulatory issues, and the public can submit comments on the meeting.